Results 191 to 200 of about 205,182 (367)

Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B‐cell lymphoma

British Journal of Haematology, EarlyView.
This study examined the effect of MYD88L265P (myeloid differentiation primary response gene 88 mutation L265P) and/or CD79BY196 (cluster of differentiation 79B gene mutation Y196) on central nervous system (CNS) relapse in 270 patients with newly diagnosed diffuse large B‐cell lymphoma.
Tomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, Hirokazu Sasaki, Takashi Kanamori, Arisa Asano, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Takaomi Sanda, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Hiroshi Inagaki   +14 more
wiley   +1 more source

Current Issues and Regulations in Tendon Regeneration and Musculoskeletal Repair with Mesenchymal Stem Cells

, 2011
Mesenchymal stem cells are multipotent stromal cells residing within the connective tissue of most organs. Their surface phenotype has been well described.
Grange, Simon
core  

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials [PDF]

, 2005
Fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) are powerful adverse prognostic indicators for relapse in acute myelold leukemia (AML) but the most efficacious therapy for FLT3/ ITD+ patients is currently unknown.
Burnett, AK, Gale, RE, Hills, R, Kottaridis, PD, Linch, DC, Srirangan, S, Wheatley, K   +6 more
core  

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non‐Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

British Journal of Haematology, EarlyView.
Summary Developing new therapeutic regimens for relapsed/refractory (R/R) B non‐Hodgkin lymphoma (NHL) patients remains a significant unmet clinical need. Our objective was to evaluate atezolizumab (ATE), obinutuzumab (OBI) and venetoclax (VEN) combination in patients with R/R NHL who had received at least one prior anti‐CD20‐containing ...
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, Stéphanie Guidez, Olivier Casasnovas, Pierre Feugier, Gandhi Damaj, Hervé Tilly, Loïc Ysebaert, Steven Le Gouill, Nadine Morineau, Emmanuel Gyan, Rémy Gressin, Roch Houot, Morgane Cheminant, Franck Morschhauser, Catherine Thieblemont, Corinne Haioun, Emmanuelle Nicolas‐Virelizier, Luc‐Matthieu Fornecker, Nicolas Daguindau, Guillaume Cartron   +21 more
wiley   +1 more source

The role of the host—Neutrophil biology

Periodontology 2000, EarlyView., 2023
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple, Josefine Hirschfeld, Alpdogan Kantarci, Asaf Wilensky, Lior Shapira   +4 more
wiley   +1 more source

Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma

, 1998
Emmanuel Katsanis, DJ Weisdorf, Jeffrey S. Miller   +2 more
openalex   +1 more source

Evidence-Based Management of Hodgkin's Disease: The Role of Autologous Stem Cell Transplantation [PDF]

, 2000
Donna Reece
openalex   +1 more source

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B‐cell lymphoma cohort

British Journal of Haematology, EarlyView.
The international prognostic index (IPI)‐driven trial inclusion criteria may have contributed to the failure of some of the first‐line trials in large B‐cell lymphoma (LBCL). GLA and LYSA collaborated to improve prognostic stratification in LBCL by analyzing data from trial cohorts and proposed the smIPI.
Umut Yılmaz, Esra Terzi Demirsoy, Fatma Keklik Karadağ, Uğur Hatipoğlu, Meral Uluköylü Mengüç, Ebru Pekgüç, Taner Tan, Eda Nuhoğlu Kantarcı, Metban Mastanzade, Ali Durdu, Merve Apaydın Kayer, Murat Özbalak, Tuğrul Elverdi, Asu Fergün Yılmaz, Deniz Gören, Tayfur Toptaş, Turgay Ulaş, Özgür Mehtap, Mehmet Sinan Dal, Olga Meltem Akay, Muhlis Cem Ar, Güray Saydam, Fevzi Altuntaş, Elif Birtaş Ateşoğlu, Burhan Ferhanoğlu   +24 more
wiley   +1 more source

An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators

British Journal of Haematology, EarlyView.
Primary vitreoretinal lymphoma is an incredibly rare non‐Hodgkin lymphoma with no clear international consensus guidelines for diagnosis and management. This study highlights the significant real‐world heterogeneity in diagnostic and management approaches of this rare condition. In particular, the incorporation of systemic therapy to initial management
Catherine Tang, Catriona Downie, Mandeep S. Sagoo, Edward Pringle, Adam Suleman, Katharine L. Lewis, Lucy Zhang, Daire Quinn, L. M. Poon, William Hann, Svetlana Cherepanoff, Luke Coyle, Shireen Kassam, Pamela McKay, Chan Y. Cheah, Anca Prica, Jeffery Smith, Nada Hamad   +17 more
wiley   +1 more source

Autologous stem cell transplantation for rapidly progressive jo‐1‐positive polymyositis with long‐term follow‐up [PDF]

, 2001
Sarah Bingham, Bridget Griffiths, Dennis McGonagle, John A. Snowden, Gareth J. Morgan, Paul Emery   +5 more
openalex   +1 more source